Find Information on a:
View all Postings for:
Search ClotCare
|
Henry I. Bussey, Pharm.D., FCCP, FAHA
Senior Editor & President, Board of Directors
Dr. Bussey was selected in 2008 to receive the GSK Distinguished Scholar in Thrombosis Award for his work to incorporate patient self-testing and online management into a better anticoagulation management system. This three-year award is provided by the Chest Foundation of the American College of Chest Physicians. Dr. Bussey served for a decade on the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy and was recently appointed to the Scientific Advisory Board of the North American Thrombosis Forum (NATF). He is a Fellow of the American College of Clinical Pharmacy, the American College of Chest Physicians, and the American Heart Association and its Council on High Blood Pressure Research. His research is clinically focused and was instrumental in the adoption of the INR for warfarin monitoring in North America. Currently, he is a professor in the College of Pharmacy at the University of Texas at Austin, is president of Genesis Clinical Research in San Antonio, TX, is co-founder of ClotCare, and is a consultant to Genesis Advanced Technologies on the development of the ClotFree system for online anticoagulation management. He has over 100 publications, is on the editorial board for Pharmacotherapy, and is a reviewer for several pharmacy and medical journals. Dr. Bussey obtained his B.S. in Pharmacy from the University of Georgia and his Pharm.D. (with a concurrent clinical pharmacy residency in Internal Medicine) from the University of Texas at Austin and the University of Texas Health Science Center in San Antonio. Dr. Bussey served recently on advisory boards for Canyon Pharmaceuticals and Ortho-McNeil; has received research support from Roche Diagnostics, Inc., Bristol Myers Squibb, Pfizer, Merck, and Novartis; and is not on the speakers' bureau of any pharmaceutical company.
Editorial Board Members
-
Henry I. Bussey, Pharm.D., FCCP, FAHA -- San Antonio, TX
-
Marie B. Walker, BBA -- Fresno, CA & San Antonio, TX
-
Mary Amato, Pharm.D., MPH -- Boston, MA
-
Jack E. Ansell, M.D. -- Boston, MA
-
William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
-
Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
-
Samuel Z. Goldhaber, M.D. -- Boston, MA
-
James B. Groce III, Pharm.D., CACP -- Greensboro, NC
-
Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
-
David W. Hawkins, Pharm.D. -- Sacramento, CA
-
Elaine M. Hylek, MD, MPH -- Boston, MA
-
Roger M. Lyons, MD, FACP -- San Antonio, TX
-
Ruth Morrison, R.N., B.S.N., C.V.N. -- Boston, MA
-
Edith A. Nutescu, Pharm.D. -- Chicago, IL
-
Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
-
Alex C. Spyropoulos, MD, FACP, FCCP -- Albuquerque, NM
-
Victor F. Tapson, M.D. -- Durham, NC
-
Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
-
Robert T. Weibert, Pharm.D. -- San Diego, CA
-
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA
Return to Editorial Board main page
|
|
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.
|